Cited 52 times since 2013 (4.5 per year) source: EuropePMC Drug discovery today, Volume 19, Issue 7, 17 3 2013, Pages 859-868 Data-driven medicinal chemistry in the era of big data. Lusher SJ, McGuire R, van Schaik RC, Nicholson CD, de Vlieg J
Science, and the way we undertake research, is changing. The increasing rate of data generation across all scientific disciplines is providing incredible opportunities for data-driven research, with the potential to transform our current practices. The exploitation of so-called 'big data' will enable us to undertake research projects never previously possible but should also stimulate a re-evaluation of all our data practices. Data-driven medicinal chemistry approaches have the potential to improve decision making in drug discovery projects, providing that all researchers embrace the role of 'data scientist' and uncover the meaningful relationships and patterns in available data.
